Neurological surgeons, often referred to as neurosurgeons, are medical experts specializing in surgical treatment of disorders affecting the brain, spinal cord, and peripheral nervous system. Their work addresses a wide range of complex conditions such as brain tumors, traumatic brain injuries, spinal cord compression, cerebrovascular diseases like aneurysms, and neurological disorders including epilepsy and Parkinson’s disease. Becoming a neurosurgeon requires many years of education and training—typically four years of medical school followed by a rigorous residency program that lasts six to eight years, often with additional fellowship training in subspecialties like pediatric neurosurgery or neuro-oncology. Neurosurgeons utilize advanced imaging techniques such as MRI, CT scans, and intraoperative neuronavigation to accurately identify and target affected areas, enabling them to perform delicate surgeries with precision while minimizing damage to critical neural structures.
Beyond the operating room, neurological surgeons collaborate closely with neurologists, radiologists, oncologists, and rehabilitation specialists to provide comprehensive care tailored to each patient’s needs. They manage both emergency cases—such as severe head trauma and stroke—and elective surgeries designed to improve neurological function and quality of life. The expertise, steady hands, and quick decision-making of neurological surgeons are essential in treating life-threatening and debilitating neurological diseases, making them indispensable in modern medicine’s efforts to protect and restore nervous system health.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States